Skip to main content
Log in

Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The ZR-75-1 ER positive breast cancer cell line,xenografted in female nude mice, has been usedto determine the effect of tamoxifen on cellproliferation (as measured by mitosis) and cell death(as evidenced by apoptosis and necrosis). After 2days treatment, there was a significant rise inapoptosis (p < 0.05), whereas a fall inmitosis was not apparent until 7 days (p< 0.05). Furthermore there was an increase inthe apoptotic : mitotic ratio on day 7(p < 0.05). These changes antedated tumour regression,which did reach not significance until day 14.Tamoxifen did not increase necrosis (which significantly decreasedin treated tumours once they had regressed (p< 0.01)). In contrast tamoxifen treatment of xenograftedMDA-MB-231 ER-negative breast cancer cells produced no significanteffects on growth, apoptosis, or mitosis. This studypresents clear evidence for tamoxifen inducing apoptosis inZR-75-1 xenografts (but not MDA-MB-231 tumours). Since changesin apoptosis and mitosis antedate tumour regression, theirassessment may provide the potential by which topredict tumour response to tamoxifen therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wolf DM, Fuqua SAW: Mechanisms of action of antiestrogens. Cancer Treat Rev 21: 247–271, 1995

    Google Scholar 

  2. Allan SG, Rodger A, Smyth JF, Leonard RCF, Chetty U, Forrest APM: Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J 290: 358–358, 1985

    Google Scholar 

  3. Gazet J-C, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, Lowndes S: Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207–214, 1994

    Google Scholar 

  4. Gaskell DJ, Hawkins RA, de Carteret S, Chetty U, Sangster K, Forrest APM: Indications for primary tamoxifen therapy in elderly women with breast cancer. Br J Surg 79: 1317–1320, 1992

    Google Scholar 

  5. Schwartzman RA, Cidlowski JA: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev 14: 133–151, 1993

    Google Scholar 

  6. Osborne CK, Boldt CH, Clark GM, Trent JM: Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43: 3583–3585, 1983

    Google Scholar 

  7. Brunner N, Bronzert D, Vindeløv LL, Rygaard K, Spang-Thomsen M, Lippman ME: Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49: 1515–1520, 1989

    Google Scholar 

  8. Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166, 1991

    Google Scholar 

  9. Warri AM, Huovinen RL, Martikainen PM, Härkönen PL: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412–1418, 1993

    Google Scholar 

  10. Brugal G, Dye R, Krief B, Chassery J-M, Tanke H, Tucker JH: HOME: Highly Optimized Microscope Environment. Cytometry 13: 109–116, 1992

    Google Scholar 

  11. Cohen JJ: Apoptosis. Immunol Today 14: 126–130, 1993

    Google Scholar 

  12. van Diest PJ, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, Bellot SM, Fijnheer J, van Gorp LHM, Kwee WS, Los J, Peterse JL, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG, Willig WPM, Ariens ATh: Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project. Hum Pathol 23: 603–607, 1992

    Google Scholar 

  13. Arends MJ, McGregor AH, Wyllie AH: Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol 144: 1045–1057, 1994

    Google Scholar 

  14. Bland JM, Altman DG: Measurement error. Br Med J 313: 744–744, 1996

    Google Scholar 

  15. Steel CG: Growth kinetics of tumours. Clarendon Press, Oxford, 1977, p 21.

    Google Scholar 

  16. Tominaga T, Yoshida Y, Matsumoto A, Hayashi K, Kosaki G: Effects of tamoxifen and the derivative (tat) on cell-cycle of MCF-7 in vitro. Anticancer Res 13: 661–666, 1993

    Google Scholar 

  17. Sarkaria JN, Gibson DFC, Jordan VC, Fowler JF, Lindstrom MJ, Mulcahy RT: Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labelling and flow cytometry. Cancer Res 530: 4413–4417, 1993

    Google Scholar 

  18. Wang TTY, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487–2489, 1995

    Google Scholar 

  19. Kristensen CA, Kristjansen PEG, Brünner N, Quistorff B, Spang-Thomsen M: Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity and apoptotic index. Cancer Res 55: 4146–4150, 1995

    Google Scholar 

  20. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257, 1972

    Google Scholar 

  21. Wijsman JH, Cornelisse CJ, Keijzer R, van de Velde CJH, Elvers B, van Dierendonck JH: Effect of hormone depletion on cell survival in the EMR-86 rat mamary carcinoma. Br J Cancer 73: 1210–1215, 1996

    Google Scholar 

  22. Gold R, Schmeid M, Giegerich G, Breischopf H, Hartung HP, Toyka KV: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219–225, 1994

    Google Scholar 

  23. Gagliardi A, Collins DC: Inhibition of angiogenesis by antioestrogens. Cancer Res 530: 533–535, 1993

    Google Scholar 

  24. Haran EF, Maretzek AF, Goldberg I, Degani H: Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 549: 5511–5514, 1994

    Google Scholar 

  25. Dowsett M, Johnston SRD, Newby J, Golding M, Sacks N, Smith IE: Mechanisms of hormone response: a role for apoptosis. Endocrine-Related Cancer 2: 3–11, 1995

    Google Scholar 

  26. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z: Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labelling of fragmented DNA. Cytometry 15: 169–175, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cameron, D., Ritchie, A., Langdon, S. et al. Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat 45, 99–107 (1997). https://doi.org/10.1023/A:1005850827825

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005850827825

Navigation